Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRFM with and without PBMSCs for Implant Stability
NCT03044119Phase 1Unknown
- Sponsor
- KLE Society's Institute of Dental Sciences
- Start
- Mar 2018
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of peripheral blood-derived mesenchymal stromal cells in edentulism (2 arms), sponsored by KLE Society's Institute of Dental Sciences. Primary endpoint: Insertion torque values at the time of placement of dental implant at Day 0. Status: unknown.
02
Drugs
peripheral blood-derived mesenchymal stromal cells
03
Conditions
edentulism
Beyond the preview
Go deeper on NCT03044119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044119.